Indias last three budgets, which can be seen as statement of economic policy, have focused on two major principles: to portray India as an attractive destination for capital, and increase in public spending to raise returns and attract private investors.
Uncertainty has descended upon the $150-billion Indian outsourcing industry in anticipation of the protectionist regime under President Trump. Protectionism has been a popular election rhetoric across nations, and more so in recent times. And the voting masses seem to like it. Will Trumps campaign cry for protectionism cross the boundaries of poetic drama and come alive as laws?
India Pharmaceutical Industry
- The Indian pharmaceutical industry is estimated to grow at 20% compound annual growth rate (CAGR) over the next five years, as per India Ratings, a Fitch Group company.
- Gujarat clocked the highest growth rate in pharmaceuticals market at 22.4% during November 2014, surpassing the industry growth rate, which grew by 10.9%.
- Also, growing at an average rate of about 20%, India's biotechnology industry comprising bio-pharmaceuticals, bio-services, bio-agriculture, bio-industry and bioinformatics may reach the $7 billion mark by the end of 2015.
- Biopharma is the largest sector contributing about 62% of the total revenue, with revenue generation to the tune of over $2.03 billion.